Ultralight

Ultralight is a US-based company specializing in advanced electronic health record (EHR) solutions designed for modern healthcare practices, emphasizing efficiency and personalized patient care through innovative technology. Co-Founded by Sunita Mohanty (CEO) and Pedro Tabio in 2024 and headquartered in San Francisco, US, Ultralight provides a specialized electronic health record system for integrative and concierge medicine. The company has undergone strategic pivots since its inception, focusing on enhancing healthcare delivery through AI-driven solutions. In April 2026, Ultralight raised an undisclosed amount in seed funding led by new investor The General Partnership, with participation from other new investors Wisdom Ventures, Anthemis, Emerson Collective, and GSBackers.

Individual and other unspecified investors also participated in the round. Ultralight’s core product offering is an advanced electronic health record (EHR) platform designed specifically for modern healthcare practices, particularly those in functional, integrative, longevity, and concierge medicine. This next-generation EHR system utilizes artificial intelligence to streamline workflows, enhance patient engagement, and deliver personalized care with efficiency. By transforming complex patient data into clear, actionable plans, Ultralight enables clinicians to reclaim significant hours each week, focusing on patient interactions rather than administrative tasks.

The platform supports a diverse client base, primarily comprising forward-thinking clinics that require high-touch, data-driven approaches to healthcare. Ultralight operates in various geographical markets, including the United States, Canada, and select regions in Europe, catering to a growing demand for precision medicine and personalized healthcare solutions. Ultralight generates revenue through a subscription-based model, where clinics pay for access to its EHR platform and associated services. The structure typically involves monthly or annual fees, allowing users to utilize the full suite of features, including AI-driven analytics, telehealth capabilities, and automated patient follow-ups.

Clients range from small, independent practices to larger, multi-physician clinics, all benefiting from the platform's ability to enhance operational efficiency and patient care. While specific pricing plans are not disclosed, the model is designed to accommodate a variety of practice sizes and needs, supporting both B2B partnerships and direct-to-consumer engagements. The company emphasizes its flagship offerings, which include tailored patient care plans and evidence-based therapy guidance, solidifying its position in the evolving landscape of healthcare technology. Ultralight plans to enhance its product offerings by developing new features and services within its EHR platform, although specific launch dates are not provided.

Recent funding will be instrumental in supporting these growth initiatives, particularly through the development of new capabilities and market penetration strategies following the USD 9. 3 mn raised in the Seed round.